Politics

Politics Rachel Cohrs

STAT Plus: In new Regeneron deal for Covid drug, White House imposes price limits for first time

First Opinion Arjun Sharma

STAT Plus: PEPFAR, one of the greatest public health inventions of our time, is at risk

Politics John Wilkerson

STAT Plus: White House touts efforts to stem cancer drug shortages

D.C. Diagnosis Sarah Owermohle

STAT Plus: Is there a path forward for PEPFAR?

Politics John Wilkerson

STAT Plus: NIH nominee Bertagnolli will get a confirmation hearing next month, Sanders says

Politics Rachel Cohrs

STAT Plus: House transparency, PBM reform bill gains bipartisan support

D.C. Diagnosis Rachel Cohrs

STAT Plus: A new House health package & hospitals’ new site-neutral talking points

Politics Rachel Cohrs

STAT Plus: House committees strike deal on health transparency, PBM reform package

Politics Rachel Cohrs

STAT Plus: Astellas withdraws lawsuit after evading Medicare drug price negotiations

Health Lev Facher

STAT Plus: Republicans say they’ll stop fentanyl at the border. But what are their plans for treatment?

Insurance Bob Herman

STAT Plus: Humana sues Biden administration over Medicare Advantage audit rule

First Opinion Andrea Ippolito

STAT Plus: Why isn’t there any enforcement of the ACA mandate to support breastfeeding?

Politics Rachel Cohrs

STAT Plus: The curious case of J&J’s Stelara, the unluckiest drug on Medicare’s list

Biotech Rachel Cohrs and Matthew Herper

STAT Plus: Here are the 10 drugs that will be up first for Medicare price negotiation

First Opinion Joseph J. Fins

STAT Plus: Every senator should fill out a legislative advance directive

Politics Rachel Cohrs

STAT Plus: AstraZeneca sues to stop Medicare drug price negotiation program

D.C. Diagnosis Rachel Cohrs

STAT Plus: Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis

Politics Damian Garde and Sarah Owermohle

STAT Plus: Drugmakers already bet big on mRNA for cancer. Why is Biden going in, too?

Politics Damian Garde

STAT Plus: Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech

Politics Sarah Owermohle and Lizzy Lawrence

STAT Plus: Republican presidential candidates spar over abortion bans

Politics John Wilkerson

STAT Plus: Ron DeSantis wants to import drugs from Canada. Biden’s FDA just blasted his plan

Exclusive Rachel Cohrs

STAT Plus: Eli Lilly CEO donates big to Mike Pence presidential super PAC

Politics Sarah Owermohle

Republicans love RFK Jr. What does that tell us about their health platforms in 2024?

Politics Sarah Owermohle

STAT Plus: Appeals court upholds limits to abortion pill

Matt's Take Matthew Herper

STAT Plus: From drug shortages to high prices, U.S. system’s shortcomings have deep roots

Politics John Wilkerson

STAT Plus: White House drug shortages task force MIA with lawmakers while Congress works on fixes

Politics Rachel Cohrs

STAT Plus: Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform

Politics Helen Branswell

CDC director overhauls leadership of center that oversaw response to Covid-19

Exclusive Sarah Owermohle

STAT Plus: Senators push IRS to launch nonprofit hospital probe